Verve Therapeutics, Inc. (VERV) Social Stream



Verve Therapeutics, Inc. (VERV): $13.80

0.46 (+3.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VERV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Verve Therapeutics Inc (VERV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VERV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 5 $92 $50 $71.8 $23.17 209.88%
2022-01-12 6 $92 $50 $74 $23.17 219.38%
2022-02-18 7 $92 $42 $69.428 $23.17 199.65%
2022-03-15 7 $92 $34 $64.285 $23.17 177.45%

The Trend in the Analyst Price Target


Over the past 178 days, VERV's average price target has gone down $15.22.

Over the past 35 weeks, VERV's average upside potential has been 61.59%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-28 NA 84 75 79.5 70.33 13.04%
2021-09-10 NA 84 75 79.5 73.99 7.45%
2021-09-18 NA 84 75 79.5 59.88 32.77%
2021-09-19 NA 84 75 79.5 59.88 32.77%
2021-12-22 6 92 50 74.0 39.10 89.26%

VERV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.71 4 1 2 0 0 7

The Trend in the Broker Recommendations


VERV's average broker recommendation rating improved by 0.09 over the prior 120 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VERV as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Verve Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 533.26% of them.
  • In terms of how Verve Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -365.99% of that group.
  • In terms of how Verve Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 476.35% of that group.
  • In terms of how Verve Therapeutics Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 250.57% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Verve Therapeutics Inc are VALN, UTHR, and TGTX.

Is VERV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9894 seconds.